BCTX NASDAQ
BriaCell Therapeutics Corp.
1W: -8.2%
1M: -4.9%
3M: -5.1%
YTD: -48.1%
1Y: -89.5%
3Y: -99.6%
5Y: +35.3%
$3.49
-0.23 (-6.18%)
Weekly Expected Move ±14.4%
$2
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$6.6M
52W Range2.98-36.9
Volume489,429
Avg Volume213,691
Beta1.63
Dividend—
Analyst Ratings
Company Info
CEOWilliam V. Williams
Employees16
SectorHealthcare
IndustryBiotechnology
IPO Date2012-03-14
Websitebriacell.com
Bellevue Centre
West Vancouver, BC V7T 2X1
CA
West Vancouver, BC V7T 2X1
CA
604 921 1810
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Latest News
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
BriaCell Announces Six Clinical Data Presentations at ASCO 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bondarenko Jamieson | 0 | — | 2022-08-01 | |
| Lustig Marc | 0 | — | 2022-08-01 | |
| Schmieg Martin E. | 0 | — | 2022-08-01 | |
| Embro-Pantalony Vaug | 0 | — | 2022-08-01 | |
| Williams Williams V. | 0 | — | 2022-08-01 |